HTR1A and myalgic encephalomeyelitis/chronic fatigue syndrome: Therefore, the 5-HT1A receptor agonist (buspirone or ipsapirone) challenge test has been used for the diagnosis of ME/CFS via measurement of prolactin or adrenocorticotropic hormone (ACTH) released from the hypothalamus [14, 50].